Actilyse 50mg Injection

Actilyse 50mg injection contains an active component as Alteplase. It is also known as recombinant tissue plasminogen activator (rt-PA), used to treat certain medical conditions involving blood clots. It is a thrombolytic agent, meaning it helps to break down blood clots. This medication is commonly used to manage acute ischemic strokes, where a blood clot blocks blood flow to the brain, leading to potential brain damage. By administering atelpase within a specific time frame after the onset of stroke symptoms, doctors aim to restore blood flow to the affected brain tissue and reduce the risk of long-term disability. By restoring blood flow to the affected brain area, Actilyse 50mg injection can help minimize the extent of brain tissue damage caused by the stroke. This can lead to a reduction in long-term disability and an improved chance of recovery for stroke patients. As with any medication, this medication can have side effects, and it may not be suitable for every patient. Common side effects include bleeding, particularly in the brain or gastrointestinal tract. Before administering it, usually, doctors assess the patient's medical history and consider any contraindications.

Actilyse 50mg injection is administered intravenously (injection in a vein) under medical supervision. Your healthcare professional will determine the specific dosage and administration guidelines based on your condition and needs.

Actilyse 50mg Injection plays a vital role in preventing the formation of harmful blood clots in your blood vessels. Thus, it helps to reduce the risk of Acute Ischemic Stroke (AIS) and Acute Myocardial Infarction (AMI) to reduce mortality and incidence of heart failure. On the other hand, it can treat acute massive pulmonary embolism (PE) in the lysis. It works by dissolving blood clots that block blood flow to the affected tissue.

store below 25°C.

1 VIAL